New developments in cranial suture research

Plastic and Reconstructive Surgery

Volumn 107, Issue 2, 2001, Pages 523-540

  Warren, S M ^a   Greenwald, J A ^a   Spector, J A ^a   Bouletreau, P ^a   Mehrara, B J ^a   Longaker, M T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DURA MATER; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SKULL SURGERY; SURGICAL TECHNIQUE; SUTURE;

EID: 0035144057     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200102000-00034     Document Type: Article

References (166)

1. From head to toe: Conservation of molecular signals regulating limb and craniofacial morphogenesis
2. Basic mechanisms in craniofacial growth
3. Etiopathogenesis of craniosynostosis
4. Craniosynostosis: Genes and mechanisms
5. Molecular genetic advances in understanding craniosynostosis
6. Craniosynostoses: Phenotypic/molecular correlations
7. Ueber den Cretinismus, namentlich in Franken, und ueber pathologische Schaedelformen
8. Acrocephaly and scaphocephaly with symmetrically distributed malformations of the extremities
9. The pathogenesis of premature cranial synostosis in man
10. Calvarial deformity regeneration following subtotal craniectomy for craniosynostosis: A case report and theoretical implications
11. Fusion of the frontal suture in the rat
12. Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse
13. TGFbeta 1, TGF-beta 2 and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro
14. Studies in cranial suture biology: I. Increased immunoreactivity for TGF-beta (β1,β2, and β3) during rat cranial suture fusion
15. Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis: II. Somatic and craniofacial growth patterns
16. Coronal suture pathology and synostotic progression in rabbits with congenital craniosynostosis
17. Craniosynostosis with autosomal dominant transmission in New Zealand white rabbits
18. Genetic studies on the skeleton of the mouse: VII. Congenital hydrocephalus
19. Demonstration of the inductive role of the brain in osteogenesis of the embryonic skull of the chicken
20. A re-examination of two skeletal mutants of the mouse, vestigialtail (vt) and congenital hydrocephalus (ch)
21. The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus
22. Regeneration of the calvarium in young normal and growth hormone-treated hypophysectomized rats
23. Calvarial and sutural re-development following craniectomy in the neonatal rabbit
24. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures
25. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro
26. Studies in cranial suture biology: II. Role of the dura in cranial suture fusion
27. Studies in cranial suture biology: Regional dura mater determines overlying suture biology
28. Studies in cranial suture biology: In vitro cranial suture fusion
29. Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion
30. Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures
31. Biomolecular mechanisms of calvarial bone induction: Immature versus mature dura mater
32. Immature versus mature dura mater. II: Differential expression of genes critical to calvarial reossification
33. A study of regeneration in parietal bone defects in rabbits
34. The role of the dura in cranial bone regeneration in the immature animal
35. Osteogenic potential of infant dural grafts in different recipient beds
36. Redevelopment of the calvaria after partial craniectomy in growing rabbits: The effect of altering dural continuity
37. Regional differences of dura osteoinduction: Squamous dura induces osteogenesis, sutural dura induces chondrogenesis, and osteogenesis
38. Inhibition and stimulation of sutural fusion in the rat calvaria
39. In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration
40. A molecular analysis of the isolated rat posterior frontal and sagittal sutures: Differences in gene expression
41. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone
42. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta
43. The transforming growth factor-beta family
44. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long tern cultures of fetal rat calvarial osteoblasts
45. Genetics of skeletogenesis
46. Specificity, diversity, and regulation in TGF-beta superfamily signaling
47. Evolution of the transforming growth factor-beta superfamily
48. TGF beta signaling receptor, transducers, and Mad proteins
49. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation with the receptor complex
50. TGF beta signaling from cell membrane to nucleus through SMAD proteins
51. Mechanisms of activation of the TGF-B receptor
52. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae
53. Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunocyto-chemistry
54. Osteoblasts synthesize and respond to transforming growth factor-Wpe beta (TGF-beta) in vitro
55. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations
56. Metalloproteinases and their inhibitors in matrix remodeling
57. Role of transforming growth factor-beta in bone remodeling
58. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures
59. Transforming growth Factor beta inhibits bone resorption in fetal rat long bone cultures
60. TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1
61. Transforming growth factor-beta enhances fracture healing in rabbit tibiae
62. TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect
63. Role of transforming growth factor beta (TGF-beta) in repairing of bone defects
64. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion
65. Studies in cranial suture biology: Up-regulation of transforming growth factor-betal and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat
66. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura matter corelates with carvarial bone information
67. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion
68. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF- beta 2 activity from fetal rat calvaria in vitro
69. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats
70. Functions of fibroblast growth factors and their receptors
71. Fibroblast growth factors in mammalian development
72. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain
73. Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats
74. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits
75. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria: An application of a new drug delivery system
76. The use of polymerase chain reaction generated nucleotide sequences as probes for hybridization
77. Regulation of fracture repair by growth factors
78. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocindiabetic rats
79. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells
80. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures
81. A confined variable region confers ligand specificity on fibroblast growth factor receptors: Implication for the origin of the immunoglobulin fold
82. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization
83. The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain
84. Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction
85. Structural and functional diversity in the FGF receptor multigene family
86. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras. GTP complex in rat pheochromocytoma PC12 cells
87. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras
88. Fibroblast growth factor receptor-2 mutations in craniosynostosis
89. Craniosynostosis and skeletal dysplasias: Fibroblast growth factor receptor defects
90. Transforming growth factor betas and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis
91. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome
92. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability
93. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
94. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault
95. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome
96. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
97. The function and evolution of Msx genes: Pointers and paradoxes
98. Hox-7 expression during murine craniofacial development
99. Expression patterns of the homeobox gene, Hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape
100. Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth
101. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development
102. Expression of a human homeobox-containing gene is regulated by 1, 25 (OH) 2D3 in bone cells
103. Msx2/Hox 8.1: A transcriptional regulator of the rat os osteocalcin promoter
104. Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice
105. Bone tissue-specific transcription of the osteocalcin gene: Role of an activator osteoblast-specific complex and suppresser hox proteins that bind the OC box
106. The rat osteocalcin fibroblast growth factor (FGF)-responsive element: An okadaic acid-sensitive. FGF-selective transcriptional response motif
107. How embryos work: A comparative view of diverse modes of cell fate specification
108. Genomic structure, chromosomal location, and evolution of the mouse Hox 8 gene
109. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis
110. The molecular basis of Boston-type craniosynostosis: The Pro148->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
111. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull
112. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans
113. Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice
114. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation
115. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development
116. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest
117. Developmental expression of two murine fibroblast growth factor receptors, flg and bek
118. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)
119. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos
120. Mutations affecting segment number polarity in Drosophila
121. The world according to hedgehog
122. Epithelial influences on skeletogenesis in the mandible of the embryonic chick
123. Tissue interactions in the development and evolution of the vertebrate head
124. Interactions and fates of avian craniofacial mesenchyme
125. Pattern formation in the facial primordia
126. Craniofacial development: A summing up
127. Vertebrate craniofacial development: The relation between ontogenetic process and morphological outcome
128. The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos
129. The role of sonic hedgehog in normal and abnormal craniofacial morphogenesis
130. Recent advances in hedgehog signaling
131. Catching a Gli-mpse of hedgehog
132. Gli1 is a target of sonic hedgehog that induces ventral neural tube development
133. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1
134. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro
135. Strike three for GLI3
136. GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families
137. Point mutations in human GLI3 cause Greig syndrome
138. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo
139. FGF- and BMP- and Shh-mediated signaling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
140. Maternal-zygotic gene interactions during formation of dorsoventral pattern in Drosophila embryos
141. Two FGF-receptor homologues of Drosophila: One is expressed in mesodermal primordium in early embryos
142. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
143. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage
144. Twist is required in head mesenchyme for cranial neural tube morphogenesis
145. Mutations of the TWIST gene in the Saethre-Chotzen syndrome
146. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome
147. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations
148. Mutations in the human TWIST gene
149. Epidermal growth factor, its receptor, and related proteins
150. The epidermal growth factor
151. New gene, nel, encoding a M(r) 93 K protein with EGF-like repeats is strongly expressed in neural tissues of early stage chick embryos
152. New gene, nel, encoding a Mr 91 K protein with EGF-like repeats is strongly expressed in neural tissues of early stage chick embryos
153. Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGFlike repeats
154. The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage
155. Human NELL-1 expressed in unilateral coronal synostosis
156. Craniofacial growth following experimental craniosynostosis and craniectomy in rabbits
157. Age as a critical factor in the success of surgical correction of craniosynostosis
158. Experimental unilateral coronal synostosis in rabbits
159. An in utero model of craniosynostosis
160. A new in utero sheep model for unilateral coronal craniosynostosis
161. The in utero correction of unilateral coronal craniosynostosis
162. Congenital bilateral coronal suture synostosis in a rabbit and craniofacial growth comparisons with experimental models
163. Experimental unilateral coronal synostosis in rabbits